# Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Esters and Lycopene

> **NCT05836909** · NA · UNKNOWN · sponsor: **Lili Yang** · enrollment: 80 (estimated)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DIETARY_SUPPLEMENT:** Swisse plus cholesterol capsule
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05836909
- **Lead sponsor:** Lili Yang
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2023-10-31
- **Final completion:** 2024-04-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05836909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05836909, "Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Esters and Lycopene". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05836909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*